2-chloroadenosine has been researched along with Histiocytosis, Langerhans-Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arceci, RJ; Braier, J; Donadieu, J; Egeler, RM; Grois, N; Ladisch, S; Pötschger, U; Webb, D; Weitzman, S; Whitlock, J | 1 |
Imamura, T; Kamizono, J; Kanegane, H; Kudo, K; Morimoto, A; Nakadate, H; Nakagawa, S; Sato, T; Shiota, Y; Tauchi, H | 1 |
1 trial(s) available for 2-chloroadenosine and Histiocytosis, Langerhans-Cell
Article | Year |
---|---|
2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
Topics: 2-Chloroadenosine; Antimetabolites; Deoxyadenosines; Female; Histiocytes; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Prospective Studies; Risk; Salvage Therapy; Treatment Outcome | 2009 |
1 other study(ies) available for 2-chloroadenosine and Histiocytosis, Langerhans-Cell
Article | Year |
---|---|
Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan.
Topics: 2-Chloroadenosine; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Data Collection; Deoxyadenosines; Drug Resistance, Neoplasm; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Japan; Male; Surveys and Questionnaires; Treatment Outcome | 2010 |